Beacon Pointe Advisors LLC Takes $3.32 Million Position in Corteva, Inc. $CTVA

Key Points

• Beacon Pointe Advisors acquired 39,166 Corteva shares worth approximately $3.32 million during the second quarter. Institutional investors collectively own 81.54% of Corteva, with BlackRock and other major firms also establishing or expanding positions.
• Corteva reported quarterly earnings of $2.30 per share, exceeding estimates of $2.24, but revenue of $6.38 billion fell short of expectations and declined 1.2% year over year. The company maintained fiscal 2026 EPS guidance of $3.60–$3.80.
• Analysts maintain a Moderate Buy consensus rating with an average price target of $91.50, compared with the stock’s recent price of $84.00. Corteva also announced a quarterly dividend of $0.18 per share, yielding approximately 0.9% annually.

Beacon Pointe Advisors LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 39,166 shares of the company's stock, valued at approximately $3,317,000.

Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Corteva during the second quarter worth $4,560,180,000. Harris Associates L P raised its holdings in Corteva by 168.1% in the 4th quarter. Harris Associates L P now owns 17,026,221 shares of the company's stock valued at $1,141,268,000 after buying an additional 10,675,052 shares during the period. Norges Bank acquired a new position in Corteva in the fourth quarter valued at about $504,001,000. Jupiter Topco LLC acquired a new position in Corteva in the second quarter valued at about $544,246,000. Finally, Bank of America Corp DE purchased a new position in Corteva during the second quarter worth about $484,927,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Price Performance

Corteva stock opened at $84.00 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. The company has a fifty day simple moving average of $82.69 and a 200-day simple moving average of $80.54. The stock has a market cap of $56.04 billion, a P/E ratio of 55.63, a price-to-earnings-growth ratio of 2.58 and a beta of 0.57. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97.

Corteva (NYSE:CTVA - Get Free Report) last posted its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the prior year, the company posted $2.20 earnings per share. Corteva's revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva's dividend payout ratio (DPR) is 47.68%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Citigroup boosted their price target on shares of Corteva from $85.00 to $86.00 and gave the company a "neutral" rating in a research note on Monday, August 3rd. Bank of America lifted their target price on shares of Corteva from $90.00 to $96.00 and gave the company a "buy" rating in a report on Monday, July 20th. Zacks Research cut Corteva from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 11th. BNP Paribas Exane raised their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada reiterated an "overweight" rating on shares of Corteva in a research note on Friday. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $91.50.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source